EHA 2010
Interviews and expert commentary from EHA 2010 — study authors and key opinion leaders discuss the findings and their clinical implications.
Audio Journal of Oncology
Rituximab Maintenance Cuts Follicular Lymphoma Recurrence Risk In Half — Phase III PRIMA Study Results
Patients in the PRIMA study who had achieved remissions for their follicular lymphoma by means of immunochemotherapy had only half the risk of recurrence if they also received maintenance therapy with
28 June 2010
0:00